journal
Journals European Respiratory Review : ...

European Respiratory Review : An Official Journal of the European Respiratory Society

https://read.qxmd.com/read/37197770/efficacy-and-safety-of-gefapixant-for-chronic-cough-a-meta-analysis-of-randomised-controlled-trials
#1
REVIEW
Min-Hsiang Chuang, I-Wen Chen, Jen-Yin Chen, Fu-Chi Kang, Chun-Ning Ho, Shao-Chun Wu, Ming Yew, Kuo-Mao Lan, Kuo-Chuan Hung
BACKGROUND: The efficacy and safety of gefapixant in adults with chronic cough remain unclear. Our objective was to assess the efficacy and safety of gefapixant using updated evidence. METHODS: MEDLINE, Cochrane Central Register of Controlled Trials (CENTRAL) and Embase databases were searched from inception through September 2022. Subgroup analysis based on dose of gefapixant ( i.e. ≤20, 45-50 and ≥100 mg twice daily for low, moderate and high doses, respectively) was performed to explore a potential dose-dependent effect...
June 30, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37197769/phenotype-overlap-in-the-natural-history-of-asthma
#2
REVIEW
Fabio L M Ricciardolo, Giuseppe Guida, Francesca Bertolini, Antonino Di Stefano, Vitina Carriero
The heterogeneity of asthma makes it challenging to unravel the pathophysiologic mechanisms of the disease. Despite the wealth of research identifying diverse phenotypes, many gaps still remain in our knowledge of the disease's complexity. A crucial aspect is the impact of airborne factors over a lifetime, which often results in a complex overlap of phenotypes associated with type 2 (T2), non-T2 and mixed inflammation. Evidence now shows overlaps between the phenotypes associated with T2, non-T2 and mixed T2/non-T2 inflammation...
June 30, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37197768/the-oesophageal-balloon-for-respiratory-monitoring-in-ventilated-patients-updated-clinical-review-and-practical-aspects
#3
REVIEW
Annemijn H Jonkman, Irene Telias, Elena Spinelli, Evangelia Akoumianaki, Lise Piquilloud
There is a well-recognised importance for personalising mechanical ventilation settings to protect the lungs and the diaphragm for each individual patient. Measurement of oesophageal pressure ( P oes ) as an estimate of pleural pressure allows assessment of partitioned respiratory mechanics and quantification of lung stress, which helps our understanding of the patient's respiratory physiology and could guide individualisation of ventilator settings. Oesophageal manometry also allows breathing effort quantification, which could contribute to improving settings during assisted ventilation and mechanical ventilation weaning...
June 30, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37137510/identifying-risk-factors-for-copd-and-adult-onset-asthma-an-umbrella-review
#4
REVIEW
Judith C S Holtjer, Lizan D Bloemsma, Rosanne J H C G Beijers, Merel E B Cornelissen, Bart Hilvering, Laura Houweling, Roel C H Vermeulen, George S Downward, Anke-Hilse Maitland-Van der Zee
BACKGROUND: COPD and adult-onset asthma (AOA) are the most common noncommunicable respiratory diseases. To improve early identification and prevention, an overview of risk factors is needed. We therefore aimed to systematically summarise the nongenetic (exposome) risk factors for AOA and COPD. Additionally, we aimed to compare the risk factors for COPD and AOA. METHODS: In this umbrella review, we searched PubMed for articles from inception until 1 February 2023 and screened the references of relevant articles...
June 30, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37137509/furin-as-a-therapeutic-target-in-cystic-fibrosis-airways-disease
#5
REVIEW
Lisa E J Douglas, James A Reihill, Bethany M Montgomery, S Lorraine Martin
Clinical management of cystic fibrosis (CF) has been greatly improved by the development of small molecule modulators of the CF transmembrane conductance regulator (CFTR). These drugs help to address some of the basic genetic defects of CFTR; however, no suitable CFTR modulators exist for 10% of people with CF (PWCF). An alternative, mutation-agnostic therapeutic approach is therefore still required. In CF airways, elevated levels of the proprotein convertase furin contribute to the dysregulation of key processes that drive disease pathogenesis...
June 30, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37137508/awake-prone-positioning-in-acute-hypoxaemic-respiratory-failure
#6
REVIEW
Bairbre A McNicholas, Miguel Ibarra-Estrada, Yonatan Perez, Jie Li, Ivan Pavlov, Aileen Kharat, David L Vines, Oriol Roca, David Cosgrave, Claude Guerin, Stephan Ehrmann, John G Laffey
Awake prone positioning (APP) of patients with acute hypoxaemic respiratory failure gained considerable attention during the early phases of the coronavirus disease 2019 (COVID-19) pandemic. Prior to the pandemic, reports of APP were limited to case series in patients with influenza and in immunocompromised patients, with encouraging results in terms of tolerance and oxygenation improvement. Prone positioning of awake patients with acute hypoxaemic respiratory failure appears to result in many of the same physiological changes improving oxygenation seen in invasively ventilated patients with moderate-severe acute respiratory distress syndrome...
June 30, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37137507/quality-of-life-in-patients-with-chronic-respiratory-failure-on-home-mechanical-ventilation
#7
JOURNAL ARTICLE
Rebecca F D'Cruz, Georgios Kaltsakas, Eui-Sik Suh, Nicholas Hart
Home mechanical ventilation (HMV) is a treatment for chronic respiratory failure that has shown clinical and cost effectiveness in patients with underlying COPD, obesity-related respiratory failure and neuromuscular disease (NMD). By treating chronic respiratory failure with adequate adherence to HMV, improvement in patient-reported outcomes including health-related quality of life (HRQoL) have been evaluated using general and disease-specific quantitative, semi-qualitative and qualitative methods. However, the treatment response in terms of trajectory of change in HRQoL is not uniform across the restrictive and obstructive disease groups...
June 30, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37076177/cytokine-targeted-therapies-for-asthma-and-copd
#8
REVIEW
Florence Schleich, Nicolas Bougard, Catherine Moermans, Mare Sabbe, Renaud Louis
Asthma affects over 300 million people worldwide and its prevalence is increasing. COPD is the third leading cause of death globally. Asthma and COPD are complex inflammatory diseases of the airways in which impaired host defences lead to increased susceptibility to pathogens, pollutants and allergens. There is a constant interplay between host and the environment. Environmental exposures can alter the lung microbiome and influence the development of sensitisation by disrupting normal immunoregulation. The underlying airway inflammation in severe asthma is heterogeneous, with upregulation of type 2 cytokines in most cases but increased neutrophilic inflammation and activated T-helper 17 mediated immunity in others...
June 30, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37076176/noncoding-rnas-in-asthmatic-airway-smooth-muscle-cells
#9
REVIEW
Bo Xiao, Liangxian Li, Dong Yao, Biwen Mo
Asthma is a complex and heterogeneous airway disease caused by genetic, environmental and epigenetic factors treated with hormones and biologics. Irreversible pathological changes to airway smooth muscle cells (ASMCs) such as hyperplasia and hypertrophy can occur in asthmatic patients. Determining the mechanisms responsible is vital for preventing such changes. In recent years, noncoding RNAs (ncRNAs), especially microRNAs, long noncoding RNAs and circular RNAs, have been found to be associated with abnormalities of the ASMCs...
June 30, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37076175/post-tuberculosis-lung-impairment-systematic-review-and-meta-analysis-of-spirometry-data-from-14%C3%A2-621-people
#10
REVIEW
Olena Ivanova, Verena Sophia Hoffmann, Christoph Lange, Michael Hoelscher, Andrea Rachow
BACKGROUND: A substantial proportion of tuberculosis patients remain with pulmonary symptoms and reduced physical capacity despite successful treatment. We performed a systematic review to analyse the burden of post-tuberculosis lung impairment measured by lung function testing. METHODS: We searched the PubMed database for articles published between database inception and November 2020 and performed meta-analyses to estimate the prevalence, type and severity of lung impairment among drug-susceptible and multidrug-resistant tuberculosis survivors...
June 30, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37019460/new-insights-into-acute-and-chronic-respiratory-failure-highlights-from-the-respiratory-failure-and-mechanical-ventilation-conference-2022
#11
EDITORIAL
Leo Heunks, Marieke L Duiverman
Highlights from the Respiratory Failure and Mechanical Ventilation Conference 2022 https://bit.ly/3HMWKTp
June 30, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37019459/-targeting-interleukin-33-and-thymic-stromal-lymphopoietin-pathways-for-novel-pulmonary-therapeutics-in-asthma-and-copd-ariel-a-calderon-colin-dimond-david-f-choy-rajita-pappu-michele-a-grimbaldeston-divya-mohan-and-kian-fan-chung-eur-respir-rev-2023-32-220144
#12
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
June 30, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37019458/noninvasive-respiratory-support-after-extubation-a-systematic-review-and-network-meta-analysis
#13
JOURNAL ARTICLE
Annalisa Boscolo, Tommaso Pettenuzzo, Nicolò Sella, Matteo Zatta, Michele Salvagno, Martina Tassone, Chiara Pretto, Arianna Peralta, Luisa Muraro, Francesco Zarantonello, Andrea Bruni, Federico Geraldini, Alessandro De Cassai, Paolo Navalesi
BACKGROUND: The effect of noninvasive respiratory support (NRS), including high-flow nasal oxygen, bi-level positive airway pressure and continuous positive airway pressure (noninvasive ventilation (NIV)), for preventing and treating post-extubation respiratory failure is still unclear. Our objective was to assess the effects of NRS on post-extubation respiratory failure, defined as re-intubation secondary to post-extubation respiratory failure (primary outcome). Secondary outcomes included the incidence of ventilator-associated pneumonia (VAP), discomfort, intensive care unit (ICU) and hospital mortality, ICU and hospital length of stay (LOS), and time to re-intubation...
June 30, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37019457/the-role-of-telemonitoring-in-patients-on-home-mechanical-ventilation
#14
JOURNAL ARTICLE
Ries van den Biggelaar, Anda Hazenberg, Marieke L Duiverman
There is a growing number of patients being treated with long-term home mechanical ventilation (HMV). This poses a challenge for the healthcare system because in-hospital resources are decreasing. The application of digital health to assist HMV care might help. In this narrative review we discuss the evidence for using telemonitoring to assist in initiation and follow-up of patients on long-term HMV. We also give an overview of available technology and discuss which parameters can be measured and how often this should be done...
June 30, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37019456/managing-respiratory-muscle-weakness-during-weaning-from-invasive-ventilation
#15
JOURNAL ARTICLE
Côme Bureau, Marine Van Hollebeke, Martin Dres
Weaning is a critical stage of an intensive care unit (ICU) stay, in which the respiratory muscles play a major role. Weakness of the respiratory muscles, which is associated with significant morbidity in the ICU, is not limited to atrophy and subsequent dysfunction of the diaphragm; the extradiaphragmatic inspiratory and expiratory muscles also play important parts. In addition to the well-established deleterious effect of mechanical ventilation on the respiratory muscles, other risk factors such as sepsis may be involved...
June 30, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/36948503/nonpharmacological-interventions-in-copd
#16
EDITORIAL
Wim Janssens, Geert M Verleden
In COPD, a holistic and yet personalised approach is mandatory if we want to improve risk management, to control symptoms and achieve disease remission. Global access to nonpharmacological interventions will be essential for these ambitious targets. https://bit.ly/3k7aGAa
March 31, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/36948502/supplemental-oxygen-and-noninvasive-ventilation
#17
JOURNAL ARTICLE
Robert L Owens, Eric Derom, Nicolino Ambrosino
The respiratory system attempts to maintain normal levels of oxygen and carbon dioxide. However, airflow limitation, parenchymal abnormalities and dysfunction of the respiratory pump may be compromised in individuals with advanced COPD, eventually leading to respiratory failure, with reduced arterial oxygen tension (hypoxaemia) and/or increased arterial carbon dioxide tension ( P aCO2 ; hypercapnia). Hypoxaemia may persist in individuals with severe COPD despite smoking cessation and optimisation of pharmacotherapy...
March 31, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/36948501/nonpharmacological-management-of-psychological-distress-in-people-with-copd
#18
REVIEW
Eleonora Volpato, Ingeborg Farver-Vestergaard, Lisa Jane Brighton, Jeannette Peters, Marieke Verkleij, Ann Hutchinson, Monique Heijmans, Andreas von Leupoldt
Psychological distress is prevalent in people with COPD and relates to a worse course of disease. It often remains unrecognised and untreated, intensifying the burden on patients, carers and healthcare systems. Nonpharmacological management strategies have been suggested as important elements to manage psychological distress in COPD. Therefore, this review presents instruments for detecting psychological distress in COPD and provides an overview of available nonpharmacological management strategies together with available scientific evidence for their presumed benefits in COPD...
March 31, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/36948500/smoking-cessation-and-vaccination
#19
JOURNAL ARTICLE
Maria Montes de Oca, Maria Eugenia Laucho-Contreras
A significant proportion of COPD patients (∼40%) continue smoking despite knowing that they have the disease. Smokers with COPD exhibit higher levels of nicotine dependence, and have lower self-efficacy and self-esteem, which affects their ability to quit smoking. Treatment should be adapted to the needs of individual patients with different levels of tobacco dependence. The combination of counselling plus pharmacotherapy is the most effective cessation treatment for COPD. In patients with severe COPD, varenicline and bupropion have been shown to have the highest abstinence rates compared with nicotine replacement therapy...
March 31, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/36948499/lung-transplantation-for-copd-pulmonary-emphysema
#20
JOURNAL ARTICLE
Geert M Verleden, Jens Gottlieb
COPD and α-1 antitrypsin deficiency emphysema remain one of the major indications for lung transplantation. If all other treatment possibilities are exhausted or not possible (including rehabilitation, oxygen therapy, noninvasive ventilation, lung volume reduction), patients may qualify for lung transplantation. Strict selection criteria are implemented with a lot of relative and absolute contraindications. Because of an ongoing donor shortage, only a minority of endstage COPD patients will finally get transplanted...
March 31, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
journal
journal
30811
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.